Predictive Oncology Profit Margin 2010-2025 | POAI
Current and historical gross margin, operating margin and net profit margin for Predictive Oncology (POAI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Predictive Oncology net profit margin as of March 31, 2025 is -629.68%.
| Predictive Oncology Annual Profit Margins |
|---|
| Predictive Oncology Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.009B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.328B | 59.20 |
| Hims & Hers Health (HIMS) | United States | $12.250B | 127.28 |
| Tempus AI (TEM) | United States | $10.726B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.629B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.081B | 63.76 |
| Hinge Health (HNGE) | United States | $3.147B | 0.00 |
| Privia Health (PRVA) | United States | $2.800B | 191.42 |
| Enovis (ENOV) | United States | $1.753B | 9.77 |
| Schrodinger (SDGR) | United States | $1.680B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.578B | 0.00 |
| Phreesia (PHR) | United States | $1.534B | 0.00 |
| Omnicell (OMCL) | United States | $1.453B | 25.64 |
| Azenta (AZTA) | United States | $1.298B | 60.34 |
| 10x Genomics (TXG) | United States | $1.122B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.644B | 0.00 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.584B | 0.00 |
| Talkspace (TALK) | United States | $0.571B | 170.50 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.406B | 0.00 |
| TruBridge (TBRG) | United States | $0.357B | 793.00 |
| Outset Medical (OM) | United States | $0.344B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.281B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.202B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.131B | 0.00 |
| Pulmonx (LUNG) | United States | $0.128B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.123B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.092B | 3.50 |
| 111 (YI) | China | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |